Companion Diagnostics: Lessons Learned and the Path Forward Fromthe Programmed Death Ligand-1 Rollout.
* Context.--Programmed death ligand-1 (PD-L1) immunohistochemistry companion diagnostic assays play a crucial role as predictive markers in patients being considered for immune checkpoint inhibitor therapy. However, because of a convergence of several factors, including recognition of increased type...
| Publicado en: | Archives of Pathology & Laboratory Medicine Vol. 147; no. 1; pp. 62 - 71 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
College of American Pathologists
Jan2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |